Logo image of EDSA

EDESA BIOTECH INC (EDSA) Stock Fundamental Analysis

NASDAQ:EDSA - Nasdaq - CA27966L3065 - Common Stock - Currency: USD

1.92  -0.04 (-1.79%)

Fundamental Rating

3

EDSA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 559 industry peers in the Biotechnology industry. EDSA has a great financial health rating, but its profitability evaluates not so good. EDSA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EDSA has reported negative net income.
EDSA had a negative operating cash flow in the past year.
EDSA had negative earnings in each of the past 5 years.
In the past 5 years EDSA always reported negative operating cash flow.
EDSA Yearly Net Income VS EBIT VS OCF VS FCFEDSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -35.48%, EDSA is in the better half of the industry, outperforming 61.18% of the companies in the same industry.
Looking at the Return On Equity, with a value of -37.57%, EDSA is in the better half of the industry, outperforming 72.45% of the companies in the same industry.
Industry RankSector Rank
ROA -35.48%
ROE -37.57%
ROIC N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
EDSA Yearly ROA, ROE, ROICEDSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EDSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EDSA Yearly Profit, Operating, Gross MarginsEDSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

8

2. Health

2.1 Basic Checks

EDSA has more shares outstanding than it did 1 year ago.
EDSA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for EDSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EDSA Yearly Shares OutstandingEDSA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EDSA Yearly Total Debt VS Total AssetsEDSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

EDSA has an Altman-Z score of 3.42. This indicates that EDSA is financially healthy and has little risk of bankruptcy at the moment.
EDSA has a Altman-Z score of 3.42. This is in the better half of the industry: EDSA outperforms 74.60% of its industry peers.
EDSA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.42
ROIC/WACCN/A
WACCN/A
EDSA Yearly LT Debt VS Equity VS FCFEDSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

EDSA has a Current Ratio of 15.73. This indicates that EDSA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 15.73, EDSA belongs to the top of the industry, outperforming 88.73% of the companies in the same industry.
A Quick Ratio of 15.73 indicates that EDSA has no problem at all paying its short term obligations.
EDSA has a Quick ratio of 15.73. This is amongst the best in the industry. EDSA outperforms 88.73% of its industry peers.
Industry RankSector Rank
Current Ratio 15.73
Quick Ratio 15.73
EDSA Yearly Current Assets VS Current LiabilitesEDSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

EDSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.30%, which is quite impressive.
EPS 1Y (TTM)34.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, EDSA will show a very strong growth in Earnings Per Share. The EPS will grow by 20.79% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y29.97%
EPS Next 2Y30.54%
EPS Next 3Y20.79%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EDSA Yearly Revenue VS EstimatesEDSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 200K 400K 600K 800K 1M
EDSA Yearly EPS VS EstimatesEDSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EDSA. In the last year negative earnings were reported.
Also next year EDSA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDSA Price Earnings VS Forward Price EarningsEDSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDSA Per share dataEDSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

EDSA's earnings are expected to grow with 20.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.54%
EPS Next 3Y20.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EDSA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDESA BIOTECH INC

NASDAQ:EDSA (6/13/2025, 8:00:02 PM)

1.92

-0.04 (-1.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-07 2025-08-07
Inst Owners43.53%
Inst Owner Change1260.14%
Ins Owners22.93%
Ins Owner Change137.67%
Market Cap13.48M
Analysts82.5
Price Target15.98 (732.29%)
Short Float %0.39%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.75%
Min EPS beat(2)-51.8%
Max EPS beat(2)0.3%
EPS beat(4)3
Avg EPS beat(4)1.99%
Min EPS beat(4)-51.8%
Max EPS beat(4)47.35%
EPS beat(8)7
Avg EPS beat(8)17.8%
EPS beat(12)11
Avg EPS beat(12)26.51%
EPS beat(16)14
Avg EPS beat(16)22.91%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.54%
PT rev (3m)-23.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41%
EPS NY rev (1m)0%
EPS NY rev (3m)35.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB 1
EV/EBITDA N/A
EPS(TTM)-1.59
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS0
BVpS2.21
TBVpS1.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.48%
ROE -37.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.73
Quick Ratio 15.73
Altman-Z 3.42
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.28%
EPS Next Y29.97%
EPS Next 2Y30.54%
EPS Next 3Y20.79%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.37%
OCF growth 3YN/A
OCF growth 5YN/A